(Q34498098)

2 August 2017

1 reference

title

Retinoids and their receptors in cancer development and chemoprevention (English)

1 reference

2 August 2017

2

Reuben Lotan

0 references

author name string

Shi-Yong Sun

series ordinal

1

1 reference

2 August 2017

1 January 2002

1 reference

Critical Reviews in Oncology Hematology

2 August 2017

1 reference

2 August 2017

41

1 reference

2 August 2017

41-55

1 reference

2 August 2017

1

1 reference

Retinoids and apoptosis: implications for cancer chemoprevention and therapy

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Retinoid-induced apoptosis in normal and neoplastic tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Retinoids in chemoprevention and differentiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Retinoids in cancer chemoprevention.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

The nuclear receptor superfamily: the second decade

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Increasing the complexity of coactivation in nuclear receptor signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Histone deacetylase activity is required for full transcriptional repression by mSin3A

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Recruitment of p300/CBP in p53-dependent signal pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Binding and modulation of p53 by p300/CBP coactivators

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Orphan nuclear receptors--new ligands and new possibilities.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

TISSUE CHANGES FOLLOWING DEPRIVATION OF FAT-SOLUBLE A VITAMIN

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Reversal of methylcholanthrene-induced changes in mouse prostates in vitro by retinoic acid and its analogues

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Dietary vitamin a and human lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Altered retinoic acid receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

The signal transducer and activator of transcription STAT5b gene is a new partner of retinoic acid receptor alpha in acute promyelocytic-like leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Molecular genetics of acute promyelocytic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

In vivo analysis of the molecular pathogenesis of acute promyelocytic leukemia in the mouse and its therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Acquisition of oncogenic potential by RAR chimeras in acute promyelocytic leukemia through formation of homodimers.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: implications for lung cancer development

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Expression of Retinoid Receptor Genes and Proteins in Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Tumor-suppressive effect of the retinoic acid receptor beta in human epidermoid lung cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Lung tumors in mice expressing an antisense RARbeta2 transgene

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Loss of retinoic acid receptor-beta expression is an early event during esophageal carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Differential expression of nuclear retinoid receptors in normal and malignant prostates

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Dominant negative mutant of retinoic acid receptor alpha inhibits retinoic acid-induced P19 cell differentiation by binding to DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Implication of RARB in epidermoid (Squamous) lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Retinoic acid-mediated repression of human papillomavirus 18 transcription and different ligand regulation of the retinoic acid receptor beta gene in non-tumorigenic and tumorigenic HeLa hybrid cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Retinoic acid receptor isoform RAR gamma 1: an antagonist of the transactivation of the RAR beta RARE in epithelial cell lines and normal human keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Transcriptional regulation of retinoic acid receptor β in retinoic acid-sensitive and -resistant P19 embryocarcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Functional inhibition of retinoic acid response by dominant negative retinoic acid receptor mutants

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Inhibition of ligand induced promoter occupancy in vivo by a dominant negative RXR

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

A cyclic AMP response element is involved in retinoic acid-dependent RAR beta 2 promoter activation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Activation of the retinoic acid receptor beta gene by 5-aza-2'-deoxycytidine in human DLD-1 colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Demethylation by 5-aza-2'-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor beta gene in human colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor beta2 promoter in breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Promoter Methylation and Silencing of the Retinoic Acid Receptor- Gene in Lung Carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Evidence for impaired retinoic acid receptor-thyroid hormone receptor AF-2 cofactor activity in human lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Modulation of retinoic acid sensitivity in lung cancer cells through dynamic balance of orphan receptors nur77 and COUP-TF and their heterodimerization

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Expression of Retinoic Acid Nuclear Receptors and Tissue Transglutaminase Is Altered in Various Tissues of Rats Fed a Vitamin A-Deficient Diet

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Effect of retinoid status on alpha, beta and gamma retinoic acid receptor mRNA levels in various rat tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Placebo-controlled trial of 13-cis-retinoic acid activity on retinoic acid receptor-beta expression in a population at high risk: implications for chemoprevention of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Nuclear retinoid acid receptor beta in bronchial epithelium of smokers before and during chemoprevention

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Retinoic acid promotion of papilloma formation in mouse skin

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

The first stage and complete promoting activity of retinoic acid but not the analog RO-10-9359.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Effects of topical treatment with fenretinide (4-HPR) and plasma vitamin A levels in patients with actinic keratoses

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Beneficial effect of low-dose systemic retinoid in combination with topical tretinoin for the treatment and prophylaxis of premalignant and malignant skin lesions in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Effects of topical tretinoin on dysplastic nevi

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

13-cis-retinoic acid in the treatment of oral leukoplakia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Chemoprevention of oral leukoplakia with vitamin A and beta carotene: an assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Topical application of vitamin A to oral leukoplakia: A clinical case series

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Long-term follow-up of larynx leukoplakia under treatment with retinyl palmitate.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Biochemoprevention for dysplastic lesions of the upper aerodigestive tract

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Highlights of the cancer chemoprevention studies in China

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Prevention of second primary tumours with etretinate in squamous cell carcinoma of the oral cavity and oropharynx. Results of a multicentric double-blind randomised study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Adjuvant treatment of stage I lung cancer with high-dose vitamin A.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the EUropean Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Can fenretinide protect women against ovarian cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Adjuvant treatment with a vitamin A analogue (etretinate) after transurethral resection of superficial bladder tumors. Final analysis of a prospective, randomized multicenter trial in Switzerland.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Differences in uptake and metabolism of retinoic acid between estrogen receptor-positive and -negative human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Recent developments in receptor-selective retinoids

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Treatment with 13-cis-retinoic acid in transfusion-dependent patients with myelodysplastic syndrome and decreased toxicity with addition of alpha-tocopherol

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Liarozole potentiates the cancer chemopreventive activity of and the up-regulation of gap junctional communication and connexin43 expression by retinoic acid and beta-carotene in 10T1/2 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Phase I evaluation of all-trans retinoic acid with and without ketoconazole in adults with solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Toxicity and Antitumor Activity of Liposome-Entrapped Retinoid Rol3-7410

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Altered metabolism of all-trans-retinoic acid in liposome-encapsulated form

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

Liposome encapsulated vitamin A compounds exhibit greater stability and diminished toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

GD2-mediated melanoma cell targeting and cytotoxicity of liposome-entrapped fenretinide

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900144-5

7 January 2021

10.1016/S1040-8428(01)00144-5

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11796231